Contact:
Company Secretary
T: +44 (0)20 7399 2772
EVP Strategy and Global Affairs
T: +44 (0)20 7399 2760
About
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,913 GBX | +3.18% | +6.34% | +6.93% |
12:50pm | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
Apr. 25 | Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024 | CI |
Contact:
Company Secretary
T: +44 (0)20 7399 2772
EVP Strategy and Global Affairs
T: +44 (0)20 7399 2760
About
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+6.93% | 5.14B | |
+25.89% | 653B | |
+27.00% | 556B | |
-6.64% | 354B | |
+20.34% | 331B | |
+3.09% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.91% | 144B |